{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T12:42:36Z","timestamp":1761568956717,"version":"build-2065373602"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.clgc.2018.02.010","type":"journal-article","created":{"date-parts":[[2018,2,23]],"date-time":"2018-02-23T22:19:52Z","timestamp":1519424392000},"page":"e831-e841","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Ki-67 as a Prognostic Marker in Upper Urinary Tract Urothelial Carcinoma: A Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"16","author":[{"given":"Chihyun","family":"Ahn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang Wook","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheol","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyeon Hoe","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3661-275X","authenticated-orcid":false,"given":"Hyung Suk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0391-2342","authenticated-orcid":false,"given":"Ja Hyeon","family":"Ku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2018.02.010_bib1","series-title":"Upper Tract Urothelial Carcinoma","first-page":"31","article-title":"Diagnosis and evaluation of upper tract urothelial carcinoma (UTUC)","author":"Colin","year":"2015"},{"key":"10.1016\/j.clgc.2018.02.010_bib2","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.eururo.2013.03.032","article-title":"European guidelines on upper tract urothelial carcinomas: 2013 Update","volume":"63","author":"Roupr\u00eat","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2018.02.010_bib3","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.urology.2010.04.020","article-title":"Troubling outcomes from population-level analysis of surgery for upper tract urothelial carcinoma","volume":"76","author":"Abouassaly","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.clgc.2018.02.010_bib4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.urology.2009.10.004","article-title":"A\u00a0population-based assessment of perioperative mortality sfter nephroureterectomy for upper-tract urothelial carcinoma","volume":"75","author":"Jeldres","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.clgc.2018.02.010_bib5","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4111\/kju.2011.52.5.310","article-title":"Prognostic factors in transitional cell carcinoma of the upper urinary tract after radical nephroureterectomy","volume":"52","author":"Cho","year":"2011","journal-title":"Korean J Urol"},{"key":"10.1016\/j.clgc.2018.02.010_bib6","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/nrurol.2011.96","article-title":"Prognostic factors for upper urinary tract urothelial carcinoma","volume":"8","author":"Chromecki","year":"2011","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.clgc.2018.02.010_bib7","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00345-011-0710-3","article-title":"Predictive factors of recurrence and survival of upper tract urothelial carcinomas","volume":"29","author":"Verhoest","year":"2011","journal-title":"World J Urol"},{"key":"10.1016\/j.clgc.2018.02.010_bib8","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.eururo.2012.02.030","article-title":"Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature","volume":"62","author":"Lughezzani","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2018.02.010_bib9","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1464-410X.2008.07659.x","article-title":"Molecular and histological markers in urothelial carcinomas of the upper urinary tract","volume":"102","author":"Eltz","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.clgc.2018.02.010_bib10","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/(SICI)1097-0142(19960815)78:4<827::AID-CNCR20>3.0.CO;2-W","article-title":"The proliferation index of MIB-1 as a prognostic factor for patients with transitional cell carcinoma of the upper urinary tract","volume":"78","author":"Chowdhury","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.clgc.2018.02.010_bib11","first-page":"1877","article-title":"Prognostic significance of Ki-67 labeling index in urothelial tumors of the renal pelvis and ureter","volume":"155","author":"Masuda","year":"1996","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.clgc.2018.02.010_bib12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1046\/j.1464-410x.2000.00726.x","article-title":"Prognostic significance of p27Kip1 and Ki-67 expression in carcinoma of the renal pelvis and ureter","volume":"86","author":"Kamai","year":"2000","journal-title":"BJU Int"},{"key":"10.1016\/j.clgc.2018.02.010_bib13","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1442-2042.2005.01159.x","article-title":"The prognostic value of p53, Ki-67 and matrix metalloproteinases MMP-2 and MMP-9 in transitional cell carcinoma of the renal pelvis and ureter","volume":"12","author":"Kamijima","year":"2005","journal-title":"Int J Urol"},{"key":"10.1016\/j.clgc.2018.02.010_bib14","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000151409","article-title":"Identification of immunohistochemical factors that predict the synchronous or metachronous development of bladder tumors in patients with upper urinary tract tumors","volume":"81","author":"Joung","year":"2008","journal-title":"Urol Int"},{"key":"10.1016\/j.clgc.2018.02.010_bib15","doi-asserted-by":"crossref","first-page":"513.e7","DOI":"10.1016\/j.urology.2010.03.070","article-title":"Expression of Ki-67 and COX-2 in patients with upper urinary tract urothelial carcinoma","volume":"76","author":"Jeon","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.clgc.2018.02.010_bib16","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.urolonc.2009.12.003","article-title":"Impact of the expression of Aurora-A, p53, and MIB-1 on the prognosis of urothelial carcinomas of the upper urinary tract","volume":"30","author":"Scarpini","year":"2012","journal-title":"Urol Oncol"},{"key":"10.1016\/j.clgc.2018.02.010_bib17","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1038\/srep04015","article-title":"Predictive value of clinicopathological markers for\u00a0the metachronous bladder cancer and prognosis of upper tract urothelial carcinoma","volume":"4","author":"Feng","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.clgc.2018.02.010_bib18","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.acuro.2014.02.015","article-title":"Impact of p53, MIB-1 and PECAM-1 expression on the prognosis of urothelial carcinoma of the renal pelvis","volume":"38","author":"Garcia-Tello","year":"2014","journal-title":"Actas Urol Esp"},{"key":"10.1016\/j.clgc.2018.02.010_bib19","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00428-014-1541-6","article-title":"Clinicopathological and prognostic significance of EZH2 expression in upper urinary tract carcinoma","volume":"464","author":"Hayashi","year":"2014","journal-title":"Virchows Arch"},{"key":"10.1016\/j.clgc.2018.02.010_bib20","first-page":"1486","article-title":"Multi-institutional validation of the predictive value of Ki-67 in patients with high grade urothelial carcinoma of the upper urinary tract","volume":"193","author":"Krabbe","year":"2015","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.clgc.2018.02.010_bib21","first-page":"1175","article-title":"Low-level Ki-67 expression as an independent predictor of bladder tumour recurrence in patients with primary upper tract urothelial carcinoma after radical nephroureterectomy","volume":"45","author":"Wu","year":"2015","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.clgc.2018.02.010_bib22","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.clgc.2018.02.010_bib23","doi-asserted-by":"crossref","first-page":"9067","DOI":"10.1200\/JCO.2004.01.0454","article-title":"Reporting recommendations for tumor marker prognostic studies","volume":"23","author":"McShane","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clgc.2018.02.010_bib24","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Stat Med"},{"key":"10.1016\/j.clgc.2018.02.010_bib25","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.clgc.2018.02.010_bib26","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/cncr.28655","article-title":"Neoadjuvant chemotherapy improves survival of patients with upper tract urothelial carcinoma","volume":"120","author":"Porten","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.clgc.2018.02.010_bib27","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/iju.12884","article-title":"Prognostic factors of recurrent disease in upper urinary tract urothelial cancer after radical nephroureterectomy: subanalysis of the multi-institutional national database of the Japanese Urological Association","volume":"22","author":"Hara","year":"2015","journal-title":"Int J Urol"},{"key":"10.1016\/j.clgc.2018.02.010_bib28","first-page":"3965","article-title":"Expression of p53 and Ki-67 as prognostic factors for survival of men with colorectal cancer","volume":"32","author":"Lumachi","year":"2012","journal-title":"Anticancer Res"},{"key":"10.1016\/j.clgc.2018.02.010_bib29","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.surg.2012.02.011","article-title":"Ki-67 predicts disease recurrence and\u00a0poor prognosis in pancreatic neuroendocrine neoplasms","volume":"152","author":"Hamilton","year":"2012","journal-title":"Surgery"},{"key":"10.1016\/j.clgc.2018.02.010_bib30","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s00345-014-1421-3","article-title":"Multi-institutional validation of the prognostic value of Ki-67 labeling index in patients treated with radical prostatectomy","volume":"33","author":"Mathieu","year":"2015","journal-title":"World J Urol"},{"key":"10.1016\/j.clgc.2018.02.010_bib31","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/bju.12263","article-title":"Ki67 is an independent predictor of oncological outcomes in patients with localized clear-cell renal cell carcinoma","volume":"113","author":"Gayed","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.clgc.2018.02.010_bib32","doi-asserted-by":"crossref","first-page":"42.e13","DOI":"10.1016\/j.urolonc.2013.05.004","article-title":"Ki-67 is an independent indicator in non-muscle invasive bladder cancer (NMIBC); combination of EORTC risk scores and Ki-67 expression could improve the risk stratification of NMIBC","volume":"32","author":"Ding","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.clgc.2018.02.010_bib33","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.7314\/APJCP.2012.13.5.2229","article-title":"A\u00a0novel molecular grading model: combination of Ki67 and VEGF in predicting tumor recurrence and progression in non-invasive urothelial bladder cancer","volume":"13","author":"Chen","year":"2012","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.clgc.2018.02.010_bib34","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1089\/end.2015.0420","article-title":"The prognostic role of Ki-67\/MIB-1 in upper urinary-tract urothelial carcinomas: a systematic review and meta-analysis","volume":"29","author":"Lei","year":"2015","journal-title":"J\u00a0Endourol"},{"key":"10.1016\/j.clgc.2018.02.010_bib35","doi-asserted-by":"crossref","first-page":"e0158891","DOI":"10.1371\/journal.pone.0158891","article-title":"Clinicopathological and prognostic value of Ki-67 expression in bladder cancer: a systematic review and meta-analysis","volume":"11","author":"Tian","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.clgc.2018.02.010_bib36","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.clbc.2015.01.005","article-title":"Proliferation determined by Ki-67 defines different pathologic response to neoadjuvant trastuzumab-based chemotherapy in HER2-positive breast cancer","volume":"15","author":"Sanchez-Munoz","year":"2015","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.clgc.2018.02.010_bib37","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0140-6736(97)02419-7","article-title":"Language bias in randomised controlled trials published in English and German","volume":"350","author":"Egger","year":"1997","journal-title":"Lancet"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767318301265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767318301265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:29:28Z","timestamp":1761564568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767318301265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S1558767318301265"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2018.02.010","relation":{},"ISSN":["1558-7673"],"issn-type":[{"type":"print","value":"1558-7673"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ki-67 as a Prognostic Marker in Upper Urinary Tract Urothelial Carcinoma: A Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2018.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}